兆科眼科-B(06622.HK) 公布,其青光眼产品组合最近再有三种药物,即拉坦前列素滴眼液、曲伏前列素滴眼液及曲伏噻吗滴眼液,获国家药监局批准上市,视同通过仿制药一致性评价。(vc/u)
(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.